Duration of Adjuvant Chemotherapy for Stage III Colon Cancer REPLY

被引：0
|
作者：
Shi, Qian [1 ]
Paul, James [2 ]
Grothey, Axel [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
[2] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 04期
关键词：
NON-INFERIORITY; TRIALS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [21] Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer
    Turner, Megan C.
    Farrow, Norma E.
    Rhodin, Kristen E.
    Sun, Zhifei
    Adam, Mohamed A.
    Mantyh, Christopher R.
    Migaly, John
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (04) : 670 - 678
  • [22] The role of adjuvant chemotherapy in stage II and III mucinous colon cancer
    Fields, Adam C.
    Lu, Pamela
    Goldberg, Joel
    Irani, Jennifer
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1190 - 1200
  • [23] Preference values associated with stage III colon cancer and adjuvant chemotherapy
    Best, Jennie H.
    Garrison, Louis P.
    Hollingworth, William
    Ramsey, Scott D.
    Veenstra, David L.
    QUALITY OF LIFE RESEARCH, 2010, 19 (03) : 391 - 400
  • [24] Utilisation of adjuvant chemotherapy for people with stage III colon cancer in NSW
    You, Hui
    Morrell, Stephen
    Lin, Enmoore
    Tervonen, Hanna
    Zhao, George
    Currow, David
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 57 - 57
  • [25] Adjuvant Chemotherapy for Stage III Colon Cancer: Does Timing Matter?
    Czaykowski, Piotr M.
    Gill, Sharlene
    Kennecke, Hagen F.
    Gordon, Vallerie L.
    Turner, Donna
    DISEASES OF THE COLON & RECTUM, 2011, 54 (09) : 1082 - 1089
  • [26] A statewide evaluation of adjuvant chemotherapy for stage III colon cancer.
    Petrelli, N. J.
    Grubbs, S. S.
    Spellman, J. E.
    English, C. L.
    Shevock, A.
    Nunley, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
    Collienne, Maike
    Arnold, Dirk
    CANCERS, 2020, 12 (09) : 1 - 12
  • [28] Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
    Hu, Huabin
    Wu, Zehua
    Wang, Chao
    Huang, Yan
    Zhang, Jianwei
    Cai, Yue
    Xie, Xiaoyu
    Li, Jianxia
    Shen, Cailu
    Li, Weiwei
    Ling, Jiayu
    Xu, Xuehu
    Deng, Yanhong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [29] The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective
    Bregni, Giacomo
    Rebuzzi, Sara Elena
    Sobrero, Alberto
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (01)
  • [30] The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective
    Giacomo Bregni
    Sara Elena Rebuzzi
    Alberto Sobrero
    Current Treatment Options in Oncology, 2019, 20
12345